Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-01

FDA Approved: LETROZOLE — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for letrozole by Accord Healthcare, Inc., resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

SUPPL AP for LETROZOLE (LETROZOLE)